Cancer Research UK has announced a £56m research network to transform the UK into a global hub for radiotherapy study.
The network, Cancer Research UK RadNet, will bring together the Universities of Cambridge, Glasgow, Leeds, Manchester and Oxford, as well as the Cancer Research UK City of London Centre, The Institute of Cancer Research and London in partnership with The Royal Marsden NHS Foundation Trust.
Cancer Research UK chief executive Michelle Mitchell said: “Radiotherapy is a cornerstone of cancer medicine, with around 3 in 10 patients receiving it as part of their primary treatment.
“Scientists will combine advances in our understanding of cancer biology with cutting-edge technology to make this treatment more precise and effective than ever before”.
The network aims to explore flash radiotherapy, which delivers pulses of radiation in high doses within a fraction of a second so healthy tissues surrounding the tumour get less damaged compared to conventional radiotherapy.
Cancer Research UK RadNet will explore different approaches to overcome hypoxia, a condition of low oxygen within tumours.
The rising incidence of cancer, technological advancements such as the introduction of mobile IORT system, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market.
Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players.The Electron IORT segment to account for the largest share of the intraoperative radiation therapy market, by method, in 2019Based on method, the intraoperative radiation therapy market is segmented into electron IORT and intraoperative brachytherapy.
The electron IORT segment is expected to account for the largest share of the intraoperative radiation therapy market in 2019.
The large share of this segment can be attributed to its advantages such as better depth dose distribution, low treatment time, and optimal dose homogeneity as compared to HDR-IORT or kV IORT.Download PDF Brochure@https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083The other cancers segment, by application, is to register the highest CAGR in the intraoperative radiation therapy market during the forecast periodBased on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head & neck cancer, and other cancers.
The other cancer application segment includes penile cancer, lung cancer, childhood cancer, colorectal cancer, endometrial & cervical cancer, and prostate cancer.
This segment is expected to grow at the fastest CAGR owing to growing research activities in new application areas of the IORT market.North America to dominate the intraoperative radiation therapy market during the forecast periodThe intraoperative radiation therapy market is segmented into four regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World.
Why You Require Mailing Lists
Targeted Radiation oncologists mailing lists could help you get connected with the best experts across the globe.
They work with radiation therapists and Radiation Oncology medical physicists to assess individual patients, determine the best management plan, and determine recovery progress.
Cancer is a leading cause of death worldwide and accounts for 8.2 million deaths and this number has been predicted to increase to 13 million by 2030.
Medicoleads’ Radiation Oncology Email List is the norm when it comes to achieving high quality leads as it contains data driven, verified contacts of over 6,000 Radiation Oncology Physicians.
Targeted Campaigns with our Radiation Oncologist Mailing List
In the new report, the CRUK team analyzed the looking habits of sixteen,148 British households for up to seven months between Gregorian calendar month and July 2017.
Among the issues were the utilization of promotional offers, the contents of the looking baskets and varied aspects of the shoppers’ lives, together with whether or not weighty.
Wealthier households perceived to be slightly larger fans of promotions than those less prosperous.
When the team divided the participants into four teams supported the proportion of things they bought on promotion, they found seventy-two of the highest cluster World Health Organization bought between thirty-eighth and eighty-two of things on promotion were overweight or weighty compared with sixty-fourth of very cheap cluster, World Health Organization bought twenty-first or less of promoted things.
The team notes that the highest cluster of promotion-chasers didn't find yourself with a lot of things in their basket, or rather more within the manner of calories than people who opted least for deals.
however, promotion-lovers did head home with a couple of twenty-fifth larger volume of food and drinks high in fat, sugar or salt.
